Financhill
Back

Nemaura Medical Quote, Financials, Valuation and Earnings

Nemaura Medical Price Quote

$0.04
0.00 (3.9%)
(Updated: May 4, 2024 at 6:29 AM ET)

Nemaura Medical Key Stats

Sell
38
Nemaura Medical (NMRD) is a Sell

Day range:
$0.04 - $0.05
52-week range:
$0.03 - $1.25
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
0%

Volume:
27.5K
Avg. volume:
28K
1-year change:
-94.75%
Market cap:
$1.2M
Revenue:
$77K
EPS:
$-0.39

How Much Does Nemaura Medical Make?

Data Unavailable

Is Nemaura Medical Growing As A Company?

Data Unavailable

Nemaura Medical Stock Price Performance

  • Did Nemaura Medical Stock Go Up Last Month?
    Nemaura Medical share price went down by -46.24% last month
  • Did NMRD's Share Price Rise Over The Last Year?
    NMRD share price fell by -94.75% over the past 1 year

What Is Nemaura Medical 52-Week High & Low?

Nemaura Medical Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Nemaura Medical?

  • How Much Debt Does Nemaura Medical Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Nemaura Medical Have?
    Cash and short term investments quarterly total is $137.4K
  • What Is Nemaura Medical’s Book Value Per Share?
    Book value per share is -0.62

Is Nemaura Medical Cash Flow Positive?

  • What Is NMRD Cash Flow From Operations?
    Cash flow from operations (TTM) is -$9.6M
  • What Is Nemaura Medical’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $2.7M
  • What Is Nemaura Medical’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$177.2K

Nemaura Medical Return On Invested Capital

Data Unavailable

Nemaura Medical Earnings Date & Stock Price

Nemaura Medical Competitors

  • Who Are Nemaura Medical's Competitors?
    Below is a list of companies who compete with Nemaura Medical or are related in some way:
    • Asensus Surgical Inc (ASXC)
    • Perspective Therapeutics Inc (CATX)
    • Retractable Technologies Inc (RVP)
    • Catheter Precision Inc (VTAK)
    • Xtant Medical Holdings Inc (XTNT)

Nemaura Medical Dividend Yield

Data Unavailable

Nemaura Medical Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: 0% -100%

Analyst Recommendations

Buy Recommendations: 1
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 1.50
Upside from Last Price: 3388.37%

Major Shareholders

  • How many NMRD shares are owned by institutional investors?
    3.3M NMRD shares are owned by institutional investors
  • How many NMRD shares are owned by insiders?
    12M NMRD shares are owned by insiders